02301nas a2200253   4500008004100000022001400041245009500055210006900150260011100219300001400330490000700344520138000351653001801731653002901749653002401778653000801802653000801810100001501818700001601833700003301849700001801882700002101900856012601921       2014                        eng d  a1570-180800aPharmacokinetic modeling of caco-2 cell permeability using genetic programming (GP) method0 aPharmacokinetic modeling of caco2 cell permeability using geneti  aEXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATESbBENTHAM SCIENCE PUBL LTDcNOV  a1112-11180 v113 a<p>An accurate prediction of the pharmacokinetic properties of orally administered drugs is of paramount importance in pharmaceutical industry. Caco-2 cell permeability is a well established parameter for assessing the drug absorption profiles of lead molecules. Due to the restrictions on animal testing, prohibitive in situ models and ethical issues, the development of predictive models is essential. Genetic programming (GP) is an artificial intelligence (AI)-based exclusively data driven modeling paradigm. Given an example input-output data, it searches and optimizes, both the structure and parameters of a well fitting linear/non-linear input-output model. Despite this novelty, GP has not been widely exploited in drug design. Accordingly, in this study we propose a GP based approach for the in silico prediction of Caco-2 cell permeability using a diverse set of molecules. The predictions yielded a high magnitude for the training and test set correlation coefficient with low RMSE, indicating accurate Caco-2 permeability prediction and generalization performance by the GP model. The predictions were better or comparable to artificial neural networks (ANN) and support vector regression (SVR) methods. The GP based modeling approach illustrated will find diverse applications in (QSAR, QSPR and QSTR) modeling for the virtual screening of large libraries.</p>10aADME modeling10aCaco-2 cell permeability10agenetic programming10aMLP10aSVR1 aVyas, Renu1 aGoel, Purva1 aKarthikeyan, Muthukumarasamy1 aTambe, S., S.1 aKulkarni, B., D.  uhttp://library.ncl.res.in/content/pharmacokinetic-modeling-caco-2-cell-permeability-using-genetic-programming-gp-method-002245nas a2200289   4500008004100000022001400041245013800055210006900193260000800262300001000270490000700280520126700287653001901554653001101573653001201584653002401596653002101620653003301641653002401674100001501698700001801713700001601731700003301747700002301780700002601803856012601829       2018                        eng d  a1545-596300aApplication of genetic programming (GP) formalism for building disease predictive models from protein-protein interactions (PPI) data0 aApplication of genetic programming GP formalism for building dis  cFEB  a27-370 v153 a<p>Protein-protein interactions (PPIs) play a vital role in the biological processes involved in the cell functions and disease pathways. The experimental methods known to predict PPIs require tremendous efforts and the results are often hindered by the presence of a large number of false positives. Herein, we demonstrate the use of a new Genetic Programming (GP) based Symbolic Regression (SR) approach for predicting PPIs related to a disease. In this case study, a dataset consisting of 135 PPI complexes related to cancer was used to construct a generic PPI predicting model with good PPI prediction accuracy and generalization ability. A high correlation coefficient (CC) magnitude of 0.893, and low root mean square error (RMSE), and mean absolute percentage error (MAPE) values of 478.221 and 0.239, respectively, were achieved for both the training and test set outputs. To validate the discriminatory nature of the model, it was applied on a dataset of diabetes complexes where it yielded significantly low CC values. Thus, the GP model developed here serves a dual purpose: (a) a predictor of the binding energy of cancer related PPI complexes, and (b) a classifier for discriminating PPI complexes related to cancer from those of other diseases.</p>10aBinding energy10acancer10aDisease10agenetic programming10amachine learning10aprotein-protein interactions10asymbolic regression1 aVyas, Renu1 aBapat, Sanket1 aGoel, Purva1 aKarthikeyan, Muthukumarasamy1 aTambe, Sanjeev, S.1 aKulkarni, Bhaskar, D.  uhttp://library.ncl.res.in/content/application-genetic-programming-gp-formalism-building-disease-predictive-models-protein